Inventor · disambiguated record
Jian Liu
Also filed as: LIU JIAN · Liu jian-kang
44 granted patents·36 pending applications·134 citations·filing 2004–2024
96Inventor score
Files withMERCK SHARP & DOHME LLC19MERCK SHARP & DOHME15UNIV XI AN JIAOTONG8LIU JIAN4MGI TECH CO LTD4
Top patents by PatentIndex Score
80 records- 0195US11484565B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 1, 2022·3 cites·18 claims
- 0294US7608622B2Imidazo[4,5-b]pyrazinone inhibitors of protein kinasesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Oct 27, 2009·53 cites·6 claims
- 0391US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0488US9981970B2Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitorsLIU JIAN·Filed 2014·Granted May 29, 2018·12 cites·10 claims
- 0586US9718828B2BTK InhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·7 cites·15 claims
- 0684US8871738B2Fused bicyclic oxazolidinone CETP inhibitorMERCK SHARP & DOHME·Filed 2012·Granted Oct 28, 2014·8 cites·60 claims
- 0783US11427616B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 30, 2022·3 cites·48 claims
- 0883US10246457B2Indazole and azaindazole Btk inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 0983US7951829B2Benzimidazole modulators of VR1JANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 31, 2011·6 cites·17 claims
- 1080US10533037B2Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereofSIMATECH INC·Filed 2015·Granted Jan 14, 2020·9 cites·3 claims
- 1180US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1279US2025206781A1Pcsk9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1378US8293900B2Acylated spiropiperidine derivatives as melanocortin-4 receptor modulatorsJIAN TIANYING·Filed 2006·Granted Oct 23, 2012·7 cites·7 claims
- 1474US7326788B2Quinolinone derivatives as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 5, 2008·8 cites·6 claims
- 1573US12209145B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 28, 2025·0 cites·29 claims
- 1673US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 1772US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 1872US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 1971US12178842B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 31, 2024·0 cites·18 claims
- 2070US2023312528A12-oxo-imidazolidine-4-carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2166US10087188B2Benzamide imidazopyrazine Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·1 cites·2 claims
- 2265US9446130B2BTK inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Sep 20, 2016·1 cites·18 claims
- 2365US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2464US7329673B2Acylated spiropiperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·2 cites·22 claims
- 2562US11802122B22-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 31, 2023·0 cites·46 claims
- 2661US8754099B2Oxadiazole beta carboline derivatives as antidiabetic compoundsGUO LIANGQIN·Filed 2011·Granted Jun 17, 2014·1 cites·17 claims
- 2761US2025136514A1Phospho-Alumino-Silicate Inorganic Polymer, And Preparation Method And Use ThereofBEIJING RES INST URANIUM GEOLOGY·Filed 2024·Application pending·0 cites
- 2859US2022349001A1Method for synchronously sequencing sense strand and antisense strand of dnaMGI TECH CO LTD·Filed 2022·Application pending·0 cites
- 2959US2022298511A1Application of combined inhibition of lncrna sammson and braf kinase in delaying adaptive drug-resistance of melanomaUNIV XI AN JIAOTONG·Filed 2021·Application pending·0 cites
- 3056US2022380338A1Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3156US2024246932A1Aryl 3-oxopiperazine carboxamides and heteroaryl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3256US2024417791A1Method for analyzing sequence of target polynucleotideMGI TECH CO LTD·Filed 2021·Application pending·0 cites
- 3355US8106070B2Substituted imidazoles as bombesin receptor subtype-3 modulatorsCHEN DAVID·Filed 2007·Granted Jan 31, 2012·0 cites·17 claims
- 3455US2023295696A1Method for loading nucleic acid molecule on solid supportMGI TECH CO LTD·Filed 2020·Application pending·0 cites
- 3555US2024376537A1Method for analyzing sequence of target polynucleotideMGI TECH CO LTD·Filed 2021·Application pending·0 cites
- 3654US11976300B2Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cellsINST BASIC MEDICAL SCIENCES CAMS·Filed 2019·Granted May 7, 2024·0 cites·4 claims
- 3754US9346825B2Fused bicyclic oxazolidinone CETP inhibitorMERCK SHARP & DOHME·Filed 2014·Granted May 24, 2016·0 cites·16 claims
- 3854US2024002397A13-amino pyrrolidine and piperidine macrocyclic orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3953US12281109B2Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 22, 2025·0 cites·13 claims
- 4053US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 4152US11976069B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2020·Granted May 7, 2024·0 cites·12 claims
- 4252US2023391795A1Macrocyclic urea orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4351US12365674B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 22, 2025·0 cites·9 claims
- 4451US12331044B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2019·Granted Jun 17, 2025·0 cites·12 claims
- 4551US2023250183A1Polypeptide that specifically binding to cd123 protein, polypeptide complexe, co-delivery system and preparation method and use thereofINST BASIC MEDICAL SCIENCES CAMS·Filed 2021·Application pending·0 cites
- 4650US10947179B22-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, composition, and method for improving function of aortic endothelial cellUNIV XI AN JIAOTONG·Filed 2019·Granted Mar 16, 2021·0 cites·7 claims
- 4749US11110075B2Use of daphnetin in improving function of aortic endothelial cellUNIV XI AN JIAOTONG·Filed 2019·Granted Sep 7, 2021·0 cites·5 claims
- 4849US2023227405A15-oxopyrrolidine-3-carboxamides as nav1.8 inhibitorsARASAPPAN ASHOK·Filed 2021·Application pending·0 cites
- 4949US2024101555A1Urea orexin receptor agonistsARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 5049US2010113473A1Aryl amide compound as an acetyl coenzyme a carboxylase inhibitorPLAYER MARK R·Filed 2009·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jian Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →